Is Nature's Sunshine Products, Inc. (NASDAQ:NATR) Trading At A 32% Discount?

Nature's Sunshine Products, Inc. (NASDAQ:NATR) currently appears to be trading at a significant discount, with its share price of US$21.51 signalling it might be 32% undervalued compared to its estimated fair value of US$31.76. This valuation is based on a 2-stage Discounted Cash Flow (DCF) model and suggests that the company's future cash flows make it an attractive investment, especially given its peers are trading at a 77% premium on average. Investors are encouraged to consider the assumptions behind DCF models and explore other fundamental factors like management and potential risks.

Original reporting
Yahoo Finance Singapore · Simply Wall St
Published Dec 10, 2025, 11:50 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Dec 10, 2025, 12:28 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Is Nature's Sunshine Products, Inc. (NASDAQ:NATR) Trading At A 32% Discount? — source image
Decision brief

The 30-second read

$NATRBullishMed
01

Why it matters

If the valuation holds, investors could benefit from a correction towards fair value, but external risks could negate gains.

02

Market read

The news is relevant for investors interested in undervalued stocks within the health sector, especially those seeking long-term growth opportunities.

03

What to watch

Potential risks include management issues, market competition, or macroeconomic factors affecting the health and wellness industry.

Timing: medium-term (next 3-6 months)

Background

The article assesses NATR's valuation using a DCF model, comparing it to peer companies trading at a 77% premium, indicating potential undervaluation.

Company-level read

Ticker impact

$NATRBullishMedium confidence
Context

The article discusses Nature's Sunshine Products, Inc. (NASDAQ:NATR), highlighting its current undervaluation based on a Discounted Cash Flow (DCF) model.

Expected impact

Potential for a 25-30% increase over the next 6-12 months if valuation assumptions hold and market conditions remain stable.

Evidence & confidence

The valuation is based on a DCF model, which is sensitive to assumptions about future cash flows and discount rates. Peer comparison indicates the stock is undervalued, but external factors and company-specific risks could affect actual performance.

$NATRBullishMedium confidence
Context

The sentiment score (0.436767) indicates a bullish outlook, supporting the view of potential upward movement. The high relevance score (0.974555) confirms the news is directly related to the ticker.

Expected impact

Likely moderate appreciation (~10-15%) over the next 3-6 months, contingent on market sentiment and company performance.

Evidence & confidence

While the valuation and sentiment are favorable, the analysis depends on assumptions about future cash flows and market conditions. Technical indicators are not provided, limiting short-term trading signals.

Market effects

The health and wellness sector may experience increased investor interest if undervalued stocks like NATR attract attention.

Limited regional impact; primarily relevant to US markets and investors.

Low; the news pertains to a US-based company with niche market exposure.

Counterpoint

The undervaluation might be due to overestimated risks or market skepticism about future cash flows, suggesting caution before entering a position.

Key entities

  • Nature's Sunshine Products, Inc.

    A health and wellness products manufacturer listed on NASDAQ.

  • Yahoo Finance Singapore

    Source of the news article.

Related articles

$NATRMedAI 8/10

Nature's Sunshine (NATR) Stock Trades Down, Here Is Why

Nature’s Sunshine (NASDAQ: NATR) shares fell 17.7% after the company reported Q2 2026 results that missed Wall Street. Revenue was $117 million, 5.4% below estimates, and adjusted EPS was $0.21, 22.2% below expectations. It also cut full-year revenue guidance to $495 million at the midpoint, down 2.5% from prior guidance.

$NATRMed

NATURES SUNSHINE PRODUCTS INC (NATR): Results of Operations and Financial Condition

NATURES SUNSHINE PRODUCTS INC (NATR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 3 natrq22026earningsrelease.htm EX-99.1 Document Nature's Sunshine Reports Second Quarter 2026 Results Net Sales up 2% to $117.0 million, Gross Profit Margin up 194 Basis Points to 73.7% LEHI, Utah – August 6, 2026 – Nature’s Sunshine Products, Inc. (Nasdaq: NATR) ("Natur

$RKLBMedAI 8/10

Rocket Lab Just Unveiled a Game-Changing Technology Worth Watching

Rocket Lab (RKLB) said it won a $397 million U.S. Space Force contract to develop, launch, and operate multiple Flatellites for the SB-AMTI program. Flatellites are slimmer, stackable satellites intended to increase deployments per launch and integrate with Rocket Lab’s Neutron rocket. The article cites analyst forecasts for revenue rising from $602M (2025) to $1.7B (2028).

$SUNEMedAI 8/10

Pentagon to invest $400m in Australian rare earth mine

Sunrise Energy Metals said the US Pentagon will provide a conditional $400 million loan commitment to develop Syerston, a proposed scandium mine in Fifield, NSW. The project targets Western supply of scandium used in defence and other sectors amid China’s export restrictions. Sunrise also said it has a deal with Lockheed Martin for 25% of output for five years.